Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question.
作者信息
Ward Robert M, Allegaert Karel, de Groot Ronald, van den Anker Johannes N
机构信息
From the *Departments of Pediatrics, Divisions of Neonatology and Pediatric Pharmacology, and Pharmacology/Toxicology, University of Utah, Salt Lake City, UT; †Neonatal Intensive Care Unit, University Hospitals Leuven; ‡Department of Development and Regeneration, Catholic University Leuven, Leuven, Belgium; §Department of Pediatrics, University Medical Center Nijmegen, the Netherlands; ¶Division of Pediatric Clinical Pharmacology, Children's National Medical Center; ‖Departments of Pediatrics, Pharmacology, Physiology and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington, DC; and **Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
出版信息
Pediatr Infect Dis J. 2014 Jun;33(6):606-7. doi: 10.1097/INF.0000000000000244.
Abstract
摘要
相似文献
1
Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question.
Pediatr Infect Dis J. 2014 Jun;33(6):606-7. doi: 10.1097/INF.0000000000000244.
2
Continuous infusion of vancomycin in neonates.
Arch Dis Child. 2013 Jun;98(6):478-9. doi: 10.1136/archdischild-2012-303197. Epub 2013 Mar 30.
3
Do we really need continuous vancomycin infusion in neonates?
Arch Dis Child. 2013 Dec;98(12):1023-4. doi: 10.1136/archdischild-2013-304687. Epub 2013 Aug 8.
4
Neonatal vancomycin continuous infusion: still a confusion?
Pediatr Infect Dis J. 2014 Jun;33(6):600-5. doi: 10.1097/INF.0000000000000243.
5
Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.
Br J Clin Pharmacol. 1998 Aug;46(2):163-7. doi: 10.1046/j.1365-2125.1998.00763.x.
6
Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F418-21. doi: 10.1136/adc.2007.128280. Epub 2008 May 1.
7
[Continuous infusion of vancomycin in pediatric critical care].
Arch Argent Pediatr. 2013 Jan-Feb;111(1):e31-4. doi: 10.5546/aap.2013.e31.
8
Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Arch Dis Child. 2013 Jun;98(6):449-53. doi: 10.1136/archdischild-2012-302765. Epub 2012 Dec 19.
9
Giving vancomycin as a continuous infusion.
Arch Dis Child Fetal Neonatal Ed. 2009 May;94(3):F233-4.
10
Continuous infusion of vancomycin less effective and safe than intermittent infusion, based on pharmacodynamic and pharmacokinetic principles.
Clin Infect Dis. 2009 Dec 15;49(12):1964-5; author reply 1965. doi: 10.1086/648506.
引用本文的文献
1
Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal.
Front Pediatr. 2019 May 14;7:188. doi: 10.3389/fped.2019.00188. eCollection 2019.
2
Prospective validation of neonatal vancomycin dosing regimens is urgently needed.
Curr Ther Res Clin Exp. 2014 Jul 14;76:51-7. doi: 10.1016/j.curtheres.2014.06.001. eCollection 2014 Dec.
3
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
Clin Pharmacokinet. 2014 Jul;53(7):581-610. doi: 10.1007/s40262-014-0147-0.
本文引用的文献
1
Neonatal vancomycin continuous infusion: still a confusion?
Pediatr Infect Dis J. 2014 Jun;33(6):600-5. doi: 10.1097/INF.0000000000000243.
2
A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates.
Pharm Res. 2014 Mar;31(3):754-67. doi: 10.1007/s11095-013-1197-y. Epub 2013 Sep 25.
3
External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.
Br J Clin Pharmacol. 2013 Apr;75(4):1068-80. doi: 10.1111/j.1365-2125.2012.04406.x.
4
Pharmacokinetics of aminoglycosides in the newborn.
Curr Pharm Des. 2012;18(21):3114-8.
5
Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats.
Hum Exp Toxicol. 2012 Jul;31(7):726-33. doi: 10.1177/0960327111433185. Epub 2012 Feb 8.
6
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4.
7
Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
Am J Med. 2010 Dec;123(12):1143-9. doi: 10.1016/j.amjmed.2010.07.025.
8
Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
Int J Antimicrob Agents. 2011 Feb;37(2):95-101. doi: 10.1016/j.ijantimicag.2010.10.013. Epub 2010 Dec 3.
9
Developmental biology of the human kidney.
Semin Fetal Neonatal Med. 2008 Jun;13(3):125-32. doi: 10.1016/j.siny.2007.10.005. Epub 2007 Dec 21.
10
Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
Clin Exp Pharmacol Physiol. 2007 Nov;34(11):1181-5. doi: 10.1111/j.1440-1681.2007.04695.x.
Zotero 插件